Safety assessment of Bacillus subtilis CU1 for use as a probiotic in humans.
Lefevre M, Racedo SM, Denayrolles M, Ripert G, Desfougères T, Lobach AR, Simon R, Pélerin F, Jüsten P, Urdaci MC.
Lefevre M, et al. Among authors: simon r.
Regul Toxicol Pharmacol. 2017 Feb;83:54-65. doi: 10.1016/j.yrtph.2016.11.010. Epub 2016 Nov 5.
Regul Toxicol Pharmacol. 2017.
PMID: 27825987
Free article.
Clinical Trial.